| abstract |
The invention relates to a pharmaceutical preparation with antihypertensive and cardioprotective effect, which α-isopropyl-α - [(N-methyl-N-homoveratryl) -γ-amino-propyl] -3,4-di-methoxyphenyl-acetonitrile in the form of a pharmacological harmless acid addition salt, 2,4,7-triamino-6-phenyl-pteridine (triamterene) and 6-chloro-3,4-dihydro-7-sulfamoyt-2H-1,2,4-benzothiadiazine-1,1-dioxide ( Hydrochlorothiazide) as active ingredients in addition to the usual carriers or auxiliary substances in the form of a single administration unit, in particular in a weight ratio of 16: 5: 2.5. |